200 related articles for article (PubMed ID: 33601250)
21. Genomic Medicine Takes the Stage, Again!
Tempero M
J Natl Compr Canc Netw; 2018 Jul; 16(7):795. PubMed ID: 30006420
[No Abstract] [Full Text] [Related]
22. Precision Oncology: Who, How, What, When, and When Not?
Schwartzberg L; Kim ES; Liu D; Schrag D
Am Soc Clin Oncol Educ Book; 2017; 37():160-169. PubMed ID: 28561651
[TBL] [Abstract][Full Text] [Related]
23. Exploiting rare driver mutations for precision cancer medicine.
Scholl C; Fröhling S
Curr Opin Genet Dev; 2019 Feb; 54():1-6. PubMed ID: 30844512
[TBL] [Abstract][Full Text] [Related]
24. Artificial intelligence in oncology.
Shimizu H; Nakayama KI
Cancer Sci; 2020 May; 111(5):1452-1460. PubMed ID: 32133724
[TBL] [Abstract][Full Text] [Related]
25. Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.
Horak P; Leichsenring J; Goldschmid H; Kreutzfeldt S; Kazdal D; Teleanu V; Endris V; Gieldon L; Allgäuer M; Volckmar AL; Dikow N; Renner M; Kirchner M; Penzel R; Ploeger C; Brandt R; Seker-Cin H; Budczies J; Heilig CE; Neumann O; Schaaf CP; Schirmacher P; Fröhling S; Stenzinger A
Genes Chromosomes Cancer; 2022 Jun; 61(6):303-313. PubMed ID: 34331337
[TBL] [Abstract][Full Text] [Related]
26. Precision oncology based on omics data: The NCT Heidelberg experience.
Horak P; Klink B; Heining C; Gröschel S; Hutter B; Fröhlich M; Uhrig S; Hübschmann D; Schlesner M; Eils R; Richter D; Pfütze K; Geörg C; Meißburger B; Wolf S; Schulz A; Penzel R; Herpel E; Kirchner M; Lier A; Endris V; Singer S; Schirmacher P; Weichert W; Stenzinger A; Schlenk RF; Schröck E; Brors B; von Kalle C; Glimm H; Fröhling S
Int J Cancer; 2017 Sep; 141(5):877-886. PubMed ID: 28597939
[TBL] [Abstract][Full Text] [Related]
27. Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.
Ortiz MV; Kobos R; Walsh M; Slotkin EK; Roberts S; Berger MF; Hameed M; Solit D; Ladanyi M; Shukla N; Kentsis A
Pediatr Blood Cancer; 2016 Aug; 63(8):1368-74. PubMed ID: 27082517
[TBL] [Abstract][Full Text] [Related]
28. Welcome to the 16th volume of
Jenkins R; Gautier L
Future Oncol; 2020 Jan; 16(1):4247-4250. PubMed ID: 31797678
[No Abstract] [Full Text] [Related]
29. Genomics and bioinformatics as pillars of precision medicine in oncology.
Canzoneri R; Lacunza E; Abba MC
Medicina (B Aires); 2019; 79(Spec 6/1):587-592. PubMed ID: 31864231
[TBL] [Abstract][Full Text] [Related]
30. [Variant interpretation in molecular pathology and oncology : An introduction].
Horak P; Leichsenring J; Kreutzfeldt S; Kazdal D; Teleanu V; Endris V; Volckmar AL; Renner M; Kirchner M; Heilig CE; Neumann O; Schirmacher P; Fröhling S; Stenzinger A
Pathologe; 2021 Jul; 42(4):369-379. PubMed ID: 33938987
[TBL] [Abstract][Full Text] [Related]
31. Special series on comparative effectiveness research: challenges to real-world solutions to quality improvement in personalized medicine.
Browman GP
J Clin Oncol; 2012 Dec; 30(34):4188-91. PubMed ID: 23071250
[No Abstract] [Full Text] [Related]
32. Implementing Precision Medicine Programs and Clinical Trials in the Community-Based Oncology Practice: Barriers and Best Practices.
Ersek JL; Black LJ; Thompson MA; Kim ES
Am Soc Clin Oncol Educ Book; 2018 May; 38():188-196. PubMed ID: 30231363
[TBL] [Abstract][Full Text] [Related]
33. Toward defining the clinically actionable genome of metastatic breast cancer.
Fröhling S
Med; 2022 Dec; 3(12):818-819. PubMed ID: 36495861
[TBL] [Abstract][Full Text] [Related]
34. The Emerging Potential for Network Analysis to Inform Precision Cancer Medicine.
Ozturk K; Dow M; Carlin DE; Bejar R; Carter H
J Mol Biol; 2018 Sep; 430(18 Pt A):2875-2899. PubMed ID: 29908887
[TBL] [Abstract][Full Text] [Related]
35. Cancer genomics and clinical practice: how can we close the gap more quickly?
Konecny GE
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):1-3. PubMed ID: 27941363
[No Abstract] [Full Text] [Related]
36. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
Miyachi H
Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
[TBL] [Abstract][Full Text] [Related]
37. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
[TBL] [Abstract][Full Text] [Related]
38. Functional precision cancer medicine-moving beyond pure genomics.
Letai A
Nat Med; 2017 Sep; 23(9):1028-1035. PubMed ID: 28886003
[TBL] [Abstract][Full Text] [Related]
39. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
Walko C; Kiel PJ; Kolesar J
Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
[TBL] [Abstract][Full Text] [Related]
40. Automatic Integration of Clinical and Genetic Data Using cBioPortal.
Brunner M; Mullen L; Jauk F; Oliver J; Cayol F; Minata J; Herrera V; Pavicic W; Luna D; Risk M; Garcia Rivello H; Benitez S
Stud Health Technol Inform; 2022 Jun; 290():799-803. PubMed ID: 35673128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
